SLNO Stock-Based Compensation
Soleno Therapeutics Inc · Stock-Based Compensation
SLNO Stock-Based Compensation
Latest reported$21.17Mperiod ending
SLNO Stock-Based Comp ($24.42K → $21.17M)
Annual stock-based compensation
High-resolution chart · PNG
SLNO stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 45,846,000 | |
| 99,958,000 | |
| 5,945,000 | |
| 2,530,000 | |
| 3,276,000 | |
| 1,500,000 | |
| 825,000 | |
| 988,000 | |
| 880,031 | |
| 871,270 | |
| 942,369 | |
| 345,435 | |
| 38,417 | |
| 24,415 |